Cubist Pharmaceuticals, Inc. (CBST)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Cubist Pharmaceuticals, Inc. (CBST)
11 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on CBST
- Faisal Laljee(1)
- Michael Cintolo(1)
- Mark Barath(1)
- J Clinton Hill(1)
- Market Folly(1)
Most popular authors
(tracked in watchlists)
- Market Folly(290)
- SA Editor Miriam Metzinger(144)
- Mike Huckman(76)
- J Clinton Hill(63)
- Michael Cintolo(59)
Most commented on authors
- Michael Cintolo(7)
- Brett Scott(7)
- J Clinton Hill(6)
- Mark Barath(5)
- Michael Becker(2)
- 2009: Positive Outlook for Biotech
- 2008 Stock Market: 51 Rays of Light
- Eight Areas to Consider About This Market
- Underdog Smallcaps: Potential Short Squeezes
- Cash Is King: Accrual Earnings Stock Screen
- Pfizer Should Buy Amgen or Wyeth - Credit Suisse
- The Long Case for Targanta Therapeutics
- Cubist Pharmaceuticals: Betting On Biotech
- Staph Buzz Spotlights Cubist, Pfizer, Encysive
- Biotech Day in Review: Eisai Buys Morphotek for $325 Million
- Cubist Pharma Focuses On Abandoned Antibiotic Market
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
3 new today)